GLYX13
-
Catalog numberB2287-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_nameL-threonyl-L-prolyl-L-prolyl-L-threoninamide ; Rapastinel
-
DescriptionGLYX-13 is an N-methyl-D-aspartate receptor (NMDAR) modulator that has characteristics of a glycine site partial agonist. Displays nootropic, neuroprotective and antinociceptive activity, and enhances learning, memory and cognition in vivo.
-
CAS Number117928-94-6
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₄H₃₈N₂O₄
-
Molecular Weight413.5
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (~15 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA N-methyl-D-aspartate receptor (NMDAR) modulator
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD20527320
-
PubChem CID14539800
-
SMILESCC(C(C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)N)N)O
-
InChiInChI=1S/C18H31N5O6/c1-9(24)13(19)18(29)23-8-4-6-12(23)17(28)22-7-3-5-11(22)16(27)21-14(10(2)25)15(20)26/h9-14,24-25H,3-8,19H2,1-2H3,(H2,20,26)(H,21,27)/t9-,10-,11+,12+,13+,14+/m1/s1
-
InChi KeyGIBQQARAXHVEGD-BSOLPCOYSA-N
-
MSDS AvailableYES
-
Gene target
-
Short nameGLYX13
-
Alternative nameGLYX13
-